Efficacy of a hepatitis C virus core antigen enzyme‐linked immunosorbent assay for the identification of ‘window‐phase’ blood donations

Abstract

These results indicate that an HCV antigen ELISA can identify almost all (94%) of viraemic donations given during the seronegative window phase of infection. The performance of the HCV antigen ELISA appears to be suitable for large-scale screening of blood donations.